Researchers say that low levels of a protein, pregnancy-associated plasma protein A (PAPPA), that is commonly seen in screening tests for chromosomal disorders in the first trimester of pregnancy is associated with adipose tissue remodeling, glucose resistance and gestational diabetes mellitus in pregnant women. The protein levels could potentially be used as both a diagnostic tool and therapeutic target in pregnant women. Read more